TerminatedNCT02234011
A Trial of Intranasal Ketamine for the Treatment of OCD
Medication studyAges 18–55United States
Understand this study
Who could participate?
This study is for people with OCD. Listed age limits: 18 years to 55 years. Other eligibility criteria apply.
- Listed locations
- BelmontSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: September 2014
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 1
- Sponsor
- Mclean Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT02234011
- Official title
Show the full official title
A Placebo-Controlled Crossover Trial of Intranasal Ketamine for the Treatment of Obsessive-Compulsive Disorder
Recruitment & locations
TerminatedBelmont
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Mclean Hospital, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including ketamine and Placebo.
Who can participate?
This study is for people with OCD. Listed age limits: 18 years to 55 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as terminated.
